Feedback / Questions
tolododekin alfa (ANK-101) - Ankyra Therap
https://www.businesswire.com/news/home/20260416992225/en/Ankyra-Therapeutics-Announces-Clinical-Presentations-on-Novel-IL-12-Anchored-Immunotherapy-at-AACR-2026
Apr 16, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next